3Beaucaire G. Evaluation of the efficacy and safety of isepsmicin compared with amikacin in the treatment of nosocomial pneumonia and septicemia[J]. J Chemother, 1995; 7(suppl2):165.
4Walter F, Vicens Q, Westhof E. Aminoglycoside- RNA interactions[ J ]. Curr Opin C hem Biol, 1999, 3: 694.
5Hermann T, Westhof E. Saccharide- RNA recognition[J].Biopolymers, 1998, 48:155.
6Blanchard SC, Fourmy D, Eason RG, et al. rRNA chemical groups required for aminoglycoside binding [ J ]. Biochemistry, 1998,37:7716.
7Griffey RH, Hofstadler SA, Sannes- Lowery KA, et al.Determinants of aminoglycoside - binding specificity for rRNA by using mass spectrometry[J]. Proc Natl Acad Sci USA, 1999,96:10129.
8Kotra LP, Haddad J, Mobashery S. Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance[J]. Antimicrob Agents Chemother, 2000,44(12) :3249.
9Tor Y, Hermann T, Westhof E. Deciphering RNA recognition[J]. Chem Biol, 1998,5(11):277.
10Litovchick A, Evdokimov AG, Lapidot A. Aminoglycoside- arginine conjugates that bind TAR RNA: synthesis, characterization, and antiviral actiyity[J ]. Biochemistry, 2000,39: 2838.
